Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Italy Pharmaceuticals and Healthcare Report Q3 2007

Published by: Business Monitor International

Published: Nov. 16, 2007 - 64 Pages


Table of Contents


Executive Summary
Table: Italy Pharmaceuticals And Healthcare Industry SWOT
Italy Political SWOT
Italy Economic SWOT
Business Environment Rankings
Western Europe
Table: Business Environment Rankings
Regional Review
Italy’s Business Environment Rankings
Economics - Long-Term Risk
Politics - Long-Term Risk
Regulatory Barriers
Domestic Sector Threat
Market Growth Potential
Market Size Ranking
Market Summary
Healthcare Sector
Regulatory Regime
Intellectual Property Developments
Pricing And Reimbursement Issues
Industry Developments
Company Developments
Eye On Recordati
Growth Continues At Chiesi
Rottapharm Makes A Splash
Table: Rottapharm Timeline
Biotech
Clinical Trials
Over-The-Counter Sector
Pharmacy Sector
Industry Forecast Scenario
Overall Market Forecast
Table: Drug Market Indicators
Key Growth Factors - Industry
Table: Health Expenditure Indicators
Key Growth Factors - Macroeconomic
Table: Italy - Macroeconomic Forecasts
Prescription Market Forecast
Table: Prescription Drug Market Indicators
OTC Market Forecast
Table: OTC Market Indicators
Generic Market Forecast
Table: Generics And Branded Market Indicators
External Trade Forecast
Table: Pharma Trade Indicators (US$mn)
Other Healthcare Data Forecasts
Table: Socio-Demographic Indicators
Competitive Landscape
Company Profiles
Leading Multinational Manufacturers
GlaxoSmithKline
Pfizer
Novartis
Sanofi-Aventis
Merck & Co
Indigenous Manufacturer
Recordati
BMI Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Sources


Abstract

The Italian pharmaceutical market should display solid growth - by regional standards - over the forecastperiod with BMI expecting a compound annual growth rate (CAGR) of 4.37% in 2006-2011. This ispartly because the Italian population is ageing at a faster rate that elsewhere in Europe. In fact, for thisvery reason, industry association Farmindustria has claimed that it is not unreasonable to expectpharmaceutical spending to grow in tandem.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008